335 related articles for article (PubMed ID: 4211573)
21. Rh hemolytic disease of the newborn: its cause and prevention.
Pollack W
Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
[No Abstract] [Full Text] [Related]
22. [Materno-fetal isoimunization by Rh].
Gibertini A; Dodesini G; Erba GF
Quad Clin Ostet Ginecol; 1967 Aug; 22(8):536-50. PubMed ID: 4976396
[No Abstract] [Full Text] [Related]
23. [3 cases of transfusion of the fetus "in utero" for severe feto-maternal blood incompatibility].
Grosieux P; Barraya PL; Leroux JP; Aubert F; Rouchy R
Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(3):350-4. PubMed ID: 5479067
[No Abstract] [Full Text] [Related]
24. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
Maas DH; Schneider J
Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
[TBL] [Abstract][Full Text] [Related]
25. [Massive feto-maternal hemorrhage and prevention of Rhesus feto-maternal incompatibility].
Quartier P; Floch C; Meir F; Fruchart MF; Brossard Y; Lejeune C
Arch Fr Pediatr; 1993 Feb; 50(2):175-6. PubMed ID: 8343031
[No Abstract] [Full Text] [Related]
26. Current clinical concepts in hemolytic disease and blood group incompatibility.
Cherry SH
Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
[No Abstract] [Full Text] [Related]
27. [Materno-fetal Rh-factor isoimmunization without hemolytic disease].
Di Palma L; Carcano G; Manzi F
Pediatria (Napoli); 1975 Jun; 83(2):317-25. PubMed ID: 809742
[No Abstract] [Full Text] [Related]
28. [Different aspects of using antirhesus immunoglobulin].
Belozerova VI
Probl Gematol Pereliv Krovi; 1979 Oct; 24(10):49-54. PubMed ID: 92019
[No Abstract] [Full Text] [Related]
29. Successful prophylaxis of Rh immunization using small doses of intravenous anti-D IgG.
Borner P; Deicher H
Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):453-4. PubMed ID: 5003526
[No Abstract] [Full Text] [Related]
30. The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulins.
Vermylen C
Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):451. PubMed ID: 5526985
[No Abstract] [Full Text] [Related]
31. [Prevention of post-partum Rh-factor isoimmunization (experience of the Hospital 1st Gynecological-Obstetrical of the Mexican Institute of Social Security)].
Cepeda AG; Sentíes L; Fiorelli FE; Garcete JA
Ginecol Obstet Mex; 1975 Feb; 37(220):83-91. PubMed ID: 804430
[No Abstract] [Full Text] [Related]
32. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies].
Schneider J
Z Geburtshilfe Perinatol; 1972 Feb; 176(1):2-16. PubMed ID: 4553933
[No Abstract] [Full Text] [Related]
33. [The Kleihauer test and directed prevention of hemolytic disease of the newborn caused by materno-fetal Rh isoimmunization].
De Luca P; Adinolfi G; Corbo M
Arch Ostet Ginecol; 1980; 85(5):481-94. PubMed ID: 6807269
[No Abstract] [Full Text] [Related]
34. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
Jedwabny A; Suchocki S; Bobrowska G
Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
[No Abstract] [Full Text] [Related]
35. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
[No Abstract] [Full Text] [Related]
36. [Immunological aspects of the prevention of hemolytic disease of the newborn].
Antonian AK
Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
[No Abstract] [Full Text] [Related]
37. [Prevention of fetomaternal immunizations].
Mahon R; Moulinier J; Dubecq JP; Lepage F; Ravina JH; Landeau MC
J Gynecol Obstet Biol Reprod (Paris); 1972; 1():Suppl 1:3-50. PubMed ID: 4634195
[No Abstract] [Full Text] [Related]
38. [Indications for and efficacy of a low-dose of anti-D immunoglobulin].
Bellati U; Morici A; Riccardi P; Serri FG; Garzetti GG
Minerva Ginecol; 1977 Feb; 29(2):91-4. PubMed ID: 404598
[No Abstract] [Full Text] [Related]
39. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
[No Abstract] [Full Text] [Related]
40. Reversal of Rh alloimmunization. Fact or fancy?
Bowman JM; Pollock JM
Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
